Home LiteratureArticle Details
PMID: 15318932 Published · ppublish English Comparative Study Journal Article Research Support, U.S. Gov't, P.H.S.

Transcriptomic changes in human breast cancer progression as determined by serial analysis of gene expression.

Breast cancer research : BCR ·Vol. 6 ·No. 5 ·2004-00-00 ·Pages R499-513

Abba MC, Drake JA, Hawkins KA, Hu Y, Sun H, Notcovich C, Gaddis S, Sahin A, Baggerly K, Aldaz CM

Abstract

Genomic and transcriptomic alterations affecting key cellular processes such us cell proliferation, differentiation and genomic stability are considered crucial for the development and progression of cancer. Most invasive breast carcinomas are known to derive from precursor in situ lesions. It is proposed that major global expression abnormalities occur in the transition from normal to premalignant stages and further progression to invasive stages. Serial analysis of gene expression (SAGE) was employed to generate a comprehensive global gene expression profile of the major changes occurring during breast cancer malignant evolution. In the present study we combined various normal and tumor SAGE libraries available in the public domain with sets of breast cancer SAGE libraries recently generated and sequenced in our laboratory. A recently developed modified t test was used to detect the genes differentially expressed. We accumulated a total of approximately 1.7 million breast tissue-specific SAGE tags and monitored the behavior of more than 25,157 genes during early breast carcinogenesis. We detected 52 transcripts commonly deregulated across the board when comparing normal tissue with ductal carcinoma in situ, and 149 transcripts when comparing ductal carcinoma in situ with invasive ductal carcinoma (P < 0.01). A major novelty of our study was the use of a statistical method that correctly accounts for the intra-SAGE and inter-SAGE library sources of variation. The most useful result of applying this modified t statistics beta binomial test is the identification of genes and gene families commonly deregulated across samples within each specific stage in the transition from normal to preinvasive and invasive stages of breast cancer development. Most of the gene expression abnormalities detected at the in situ stage were related to specific genes in charge of regulating the proper homeostasis between cell death and cell proliferation. The comparison of in situ lesions with fully invasive lesions, a much more heterogeneous group, clearly identified as the most importantly deregulated group of transcripts those encoding for various families of proteins in charge of extracellular matrix remodeling, invasion and cell motility functions.

MeSH Terms
Apoptosis Breast Neoplasms/genetics,pathology Carcinoma, Ductal, Breast/genetics,pathology Carcinoma, Intraductal, Noninfiltrating/genetics,pathology Cell Cycle Cell Division Extracellular Matrix Gene Expression Gene Expression Profiling Gene Library Humans NF-kappa B Neoplasm Invasiveness/genetics Neoplasm Metastasis/genetics Tumor Necrosis Factor-alpha
Chemicals
NF-kappa B Tumor Necrosis Factor-alpha
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Abba Martin C
Department of Carcinogenesis, The University of Texas MD Anderson Cancer Center, Science Park - Research Division, Smithville, Texas, USA. [email protected]
Drake Jeffrey A
Hawkins Kathleen A
Hu Yuhui
Sun Hongxia
Notcovich Cintia
Gaddis Sally
Sahin Aysegul
Baggerly Keith
Aldaz C Marcelo
References (57)
57 references, click to expand
  1. Oncostatin M and leukemia inhibitory factor regulate the growth of normal human breast epithelial cells.
    Growth Factors. 2001;19(3):153-62 PMID: 11811789
  2. In silico comparison of the transcriptome derived from purified normal breast cells and breast tumor cell lines reveals candidate upregulated genes in breast tumor cells.
    Genomics. 2002 Feb;79(2):257-65 PMID: 11829496
  3. The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia.
    Lab Invest. 1999 Oct;79(10):1311-23 PMID: 10532593
  4. SPARC regulates the expression of collagen type I and transforming growth factor-beta1 in mesangial cells.
    J Biol Chem. 1999 Nov 5;274(45):32145-52 PMID: 10542250
  5. Expression of MMP-2 and MMP-9, their inhibitors, and the activator MT1-MMP in primary breast carcinomas.
    J Pathol. 1999 Oct;189(2):161-8 PMID: 10547569
  6. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer.
    Cancer Res. 1999 Nov 1;59(21):5464-70 PMID: 10554019
  7. Vimentin contributes to human mammary epithelial cell migration.
    J Cell Sci. 1999 Dec;112 ( Pt 24):4615-25 PMID: 10574710
  8. Control of apoptosis by Rel/NF-kappaB transcription factors.
    Oncogene. 1999 Nov 22;18(49):6910-24 PMID: 10602466
  9. Cancer statistics, 2000.
    CA Cancer J Clin. 2000 Jan-Feb;50(1):7-33 PMID: 10735013
  10. Overexpression of clusterin in human breast carcinoma.
    Am J Pathol. 2000 Aug;157(2):393-9 PMID: 10934144
  11. Lumican and decorin are differentially expressed in human breast carcinoma.
    J Pathol. 2000 Nov;192(3):313-20 PMID: 11054714
  12. Failure of Bcl-2 to block mitochondrial dysfunction during TRAIL-induced apoptosis. Tumor necrosis-related apoptosis-inducing ligand.
    Int J Oncol. 2001 Jan;18(1):187-94 PMID: 11115558
  13. Matrix metalloproteinases in tumor invasion and metastasis.
    Semin Cancer Biol. 2000 Dec;10(6):415-33 PMID: 11170864
  14. Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers.
    Int J Oncol. 2001 Mar;18(3):521-6 PMID: 11179481
  15. POWER_SAGE: comparing statistical tests for SAGE experiments.
    Bioinformatics. 2000 Nov;16(11):953-9 PMID: 11159306
  16. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells.
    Cancer Res. 2001 Jul 1;61(13):5168-78 PMID: 11431356
  17. A SAGE (serial analysis of gene expression) view of breast tumor progression.
    Cancer Res. 2001 Aug 1;61(15):5697-702 PMID: 11479200
  18. NF-kappaB signaling pathways in mammalian and insect innate immunity.
    Genes Dev. 2001 Sep 15;15(18):2321-42 PMID: 11562344
  19. Complexes of tetraspanins with integrins: more than meets the eye.
    J Cell Sci. 2001 Dec;114(Pt 23):4143-51 PMID: 11739647
  20. All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.
    J Cell Sci. 2002 Feb 15;115(Pt 4):679-88 PMID: 11865024
  21. Regulation of stromal versican expression by breast cancer cells and importance to relapse-free survival in patients with node-negative primary breast cancer.
    Clin Cancer Res. 2002 Apr;8(4):1054-60 PMID: 11948113
  22. New functions for the matrix metalloproteinases in cancer progression.
    Nat Rev Cancer. 2002 Mar;2(3):161-74 PMID: 11990853
  23. Clusterin/apolipoprotein J in human aging and cancer.
    Int J Biochem Cell Biol. 2002 Nov;34(11):1430-48 PMID: 12200037
  24. The desmoplastic response to infiltrating breast carcinoma: gene expression at the site of primary invasion and implications for comparisons between tumor types.
    Cancer Res. 2002 Sep 15;62(18):5351-7 PMID: 12235006
  25. Polymorphic variants of NFKB1 and its inhibitory protein NFKBIA, and their involvement in sporadic breast cancer.
    Cancer Lett. 2002 Dec 15;188(1-2):103-7 PMID: 12406554
  26. Reduced expression of the small leucine-rich proteoglycans, lumican, and decorin is associated with poor outcome in node-negative invasive breast cancer.
    Clin Cancer Res. 2003 Jan;9(1):207-14 PMID: 12538471
  27. In silico analysis of the EPS8 gene family: genomic organization, expression profile, and protein structure.
    Genomics. 2003 Feb;81(2):234-44 PMID: 12620401
  28. SC1/hevin. An extracellular calcium-modulated protein that binds collagen I.
    J Biol Chem. 2003 Mar 28;278(13):11351-8 PMID: 12538579
  29. Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer.
    Int J Cancer. 2004 Jan 1;108(1):23-30 PMID: 14618611
  30. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Eur J Hum Genet. 2004 May;12(5):347-54 PMID: 14872199
  31. Molecular and cellular biology of intermediate filaments.
    Annu Rev Biochem. 1988;57:593-625 PMID: 3052284
  32. Regulation of cell-substrate adhesion by proteoglycans immobilized on extracellular substrates.
    J Biol Chem. 1989 May 15;264(14):8012-8 PMID: 2470739
  33. Biology and natural history of breast cancer.
    Int J Cancer Suppl. 1990;5:5-21 PMID: 2258266
  34. Serial analysis of gene expression.
    Science. 1995 Oct 20;270(5235):484-7 PMID: 7570003
  35. Mitogen-inducible SIPA1 is mapped to the conserved syntenic groups of chromosome 19 in mouse and chromosome 11q13.3 centromeric to BCL1 in human.
    Genomics. 1997 Jan 1;39(1):66-73 PMID: 9027487
  36. Experimental co-expression of vimentin and keratin intermediate filaments in human breast cancer cells results in phenotypic interconversion and increased invasive behavior.
    Am J Pathol. 1997 Feb;150(2):483-95 PMID: 9033265
  37. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma.
    Am J Pathol. 1997 Feb;150(2):497-507 PMID: 9033266
  38. Gene expression profiles in normal and cancer cells.
    Science. 1997 May 23;276(5316):1268-72 PMID: 9157888
  39. Constitutive activation of NF-kappaB during progression of breast cancer to hormone-independent growth.
    Mol Cell Biol. 1997 Jul;17(7):3629-39 PMID: 9199297
  40. Rel/NF-kappa B and I kappa B proteins: an overview.
    Semin Cancer Biol. 1997 Apr;8(2):63-73 PMID: 9299584
  41. A model for p53-induced apoptosis.
    Nature. 1997 Sep 18;389(6648):300-5 PMID: 9305847
  42. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma.
    Cancer Res. 1998 Jan 15;58(2):232-6 PMID: 9443398
  43. Expression of lumican in human breast carcinoma.
    Cancer Res. 1998 Apr 1;58(7):1348-52 PMID: 9537227
  44. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
    Breast Cancer Res Treat. 1998 Mar;48(2):165-74 PMID: 9596488
  45. Oncostatin M-specific receptor expression and function in regulating cell proliferation of normal and malignant mammary epithelial cells.
    Cytokine. 1998 Apr;10(4):295-302 PMID: 9617575
  46. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation.
    APMIS. 1999 Jan;107(1):111-9 PMID: 10190287
  47. Formation of hyaluronan- and versican-rich pericellular matrix is required for proliferation and migration of vascular smooth muscle cells.
    Arterioscler Thromb Vasc Biol. 1999 Apr;19(4):1004-13 PMID: 10195929
  48. A novel lipopolysaccharide-induced transcription factor regulating tumor necrosis factor alpha gene expression: molecular cloning, sequencing, characterization, and chromosomal assignment.
    Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4518-23 PMID: 10200294
  49. Dynamics of gene expression revealed by comparison of serial analysis of gene expression transcript profiles from yeast grown on two different carbon sources.
    Mol Biol Cell. 1999 Jun;10(6):1859-72 PMID: 10359602
  50. Proteolysis in human breast and colorectal cancer.
    Br J Cancer. 1999 Sep;81(2):287-93 PMID: 10496354
  51. Molecular markers in ductal carcinoma in situ of the breast.
    Mol Cancer Res. 2003 Mar;1(5):362-75 PMID: 12651909
  52. Loss of clusterin both in serum and tissue correlates with the tumorigenesis of esophageal squamous cell carcinoma via proteomics approaches.
    World J Gastroenterol. 2003 Apr;9(4):650-4 PMID: 12679903
  53. Nuclear localization of Y-box factor YB1 requires wild-type p53.
    Oncogene. 2003 May 8;22(18):2782-94 PMID: 12743601
  54. Transactivation of vimentin by beta-catenin in human breast cancer cells.
    Cancer Res. 2003 May 15;63(10):2658-64 PMID: 12750294
  55. Differential expression in SAGE: accounting for normal between-library variation.
    Bioinformatics. 2003 Aug 12;19(12):1477-83 PMID: 12912827
  56. Identification and characterization of the cytoplasmic protein TRAF4 as a p53-regulated proapoptotic gene.
    J Biol Chem. 2003 Sep 19;278(38):36435-44 PMID: 12788948
  57. Synergistic interactions of chemotherapeutic drugs and tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand on apoptosis and on regression of breast carcinoma in vivo.
    Cancer Res. 2003 Sep 1;63(17):5390-400 PMID: 14500373
Article Info
Journal
Breast cancer research : BCR
Abbr.
Breast Cancer Res
ISSN
1465-542X
Published
2004-00-00
Epub
2004-00-06
Pages
R499-513
Language
English
Region
England
NLM ID
100927353
PMCID
PMC549167
Subset
IM
Grants
NCI NIH HHS · U19 CA084978 · United States
NCI NIH HHS · 1U19 CA84978 · United States
Corrections
ErratumIn
-
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]